Use polymerase chain reactions minimal residual disease acute lymphoblastic leukemia patients T-cell receptor TCR delta gene rearrangements acute lymphoblastic leukemia ALL patients preferential usage specific genetic elements different ALL subtypes DJ delta rearrangements T-ALL B-precursor ALLs recombination delta delta strategy detection minimal residual disease MRD isolation clonospecific probes vitro amplification delta DJ delta junctions polymerase chain reaction PCR method preparation specific delta delta fragments present study clonospecific probes T-ALL cALL patients children adults sensitivity probes residual leukemia cells semiquantitative evaluation dilution experiments PCR analysis bone marrow BM peripheral blood PB samples patients complete clinical remission following results Evidence MRD BM patients months remission induction cases maintenance therapy months diagnosis contrast patients months termination treatment apparent evidence leukemia DNA exception girl residual cells PB years diagnosis Longitudinal analysis patients marked individual differences intervals achievement clinical remission complete eradication leukemia cell clone duration MRD distinct clinical-hematologic features Detection residual disease PCR clinical relapse cases 